|
|
||||||||
Institut für Chemie 1: Nuklearchemie der KFA Jülich GmbH, D-5170 Jülich, FRG
Correspondence: For reprints contact: Dr. Gerhard Stöcklin, Institut für Chemie l, Nuklearchemie der KFA Jülich GmbH. D-5170 Jülich, FRG.
ABSTRACT
We have prepared four different 1,4-benzodiazepines, labeled at C-7 with the1.6-hr positron emitter Br-75 or the 57-hr gamma emitter Br-77, as potential radiopharmaceuticalsfor the mapping of cerebral benzodiazepine receptor areas. The triazene method was used and optimized. Yields at the no-carrier-added level were 20 %. 7-[75Br]-5-( 2-fluorophenyl )-1 -methyl-1,3-dihydro-2H-1,4-benzodiazepine-2-one (Br-75 BFB) was isolated with a minimum specific activity of 20,000CI/mmole. Biodistribution in mice shows that BFB is taken up rapidly by the brain and is retained there at useful concentrations for significant periods of time. The maximum uptake is observed at 0.25 min. Brain-to-blood concentration ratios are larger than 2 during the interval (0.25 to 10 min) investigated.
This article has been cited by other articles:
![]() |
K. Frey, B. Agranoff, A. Young, R. Hichwa, and R. Ehrenkaufer Human brain receptor distribution Science, June 6, 1986; 232(4755): 1269 - 1270. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |